Elham Rezaee

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Molecular Docking

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Iranian journal of pharmaceutical research : IJPR

This page only lists publications with an associated author ORCID identifier.

Publications

Yasaman Rezaee, Elham Rezaee, Leila Karami, Maryam Torshabi, Azadeh Haeri
Crocin-Phospholipid Complex: Molecular Docking, Molecular Dynamics Simulation, Preparation, Characterization, and Antioxidant Activity. Iranian journal of pharmaceutical research : IJPR 23 (1) (2024)
Yasaman Rezaee, Elham Rezaee, Leila Karami, Maryam Torshabi, Azadeh Haeri
Crocin-Phospholipid Complex: Molecular Docking, Molecular Dynamics Simulation, Preparation, Characterization, and Antioxidant Activity. Iranian journal of pharmaceutical research : IJPR 23 (1) (2024)
Maryam Nili Ahmadabadi, Elham Rezaee, Manijeh Nematpour, Leila Karami, Shaya Mokhtari, Farzad Kobarfard, Sayyed Abbas Tabatabai
Synthesis, Molecular Dynamics Simulation, and In-vitro Antitumor Activity of Quinazoline-2,4,6-triamine Derivatives as Novel EGFR Tyrosine Kinase Inhibitors. Iranian journal of pharmaceutical research : IJPR 21 (1) (2023)
Erfan Abdollahizad, Simin Dadashzadeh, Shima Bahri, Zahra Abbasian, Elham Rezaee
Amphotericin B Pharmacokinetics: Inter-strain Differences in Rats Following Intravenous Administration of the Most Commonly Marketed Formulations of the Drug. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Erfan Abdollahizad, Simin Dadashzadeh, Shima Bahri, Zahra Abbasian, Elham Rezaee
Amphotericin B Pharmacokinetics: Inter-strain Differences in Rats Following Intravenous Administration of the Most Commonly Marketed Formulations of the Drug. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Shima Bahri, Erfan Abdollahizad, Iman Mahlooji, Elham Rezaee, Zahra Abbasian, Simin Dadashzadeh
Cerasome Versus Liposome: A Comparative Pharmacokinetic Analysis Following Intravenous Administration into Rats. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Maryam Nili Ahmadabadi, Elham Rezaee, Manijeh Nematpour, Leila Karami, Shaya Mokhtari, Farzad Kobarfard, Sayyed Abbas Tabatabai
Synthesis, Molecular Dynamics Simulation, and In-vitro Antitumor Activity of Quinazoline-2,4,6-triamine Derivatives as Novel EGFR Tyrosine Kinase Inhibitors. Iranian journal of pharmaceutical research : IJPR 21 (1) (2023)
Shima Bahri, Erfan Abdollahizad, Iman Mahlooji, Elham Rezaee, Zahra Abbasian, Simin Dadashzadeh
Cerasome Versus Liposome: A Comparative Pharmacokinetic Analysis Following Intravenous Administration into Rats. Iranian journal of pharmaceutical research : IJPR 22 (1) (2023)
Manijeh Nematpour, Elham Rezaee, Maryam Nazari, Omid Hosseini, Sayyed Abbas Tabatabai
Targeting EGFR Tyrosine Kinase: Design, Synthesis and Biological Evaluation of Novel Quinazolinone Derivatives. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Mehrnaz Lotfaliei, Elham Rezaee, Zahra Hajimahdi, Mohammad Mahboubi Rabbani, Rezvan Zabihollahi, Mohammad Reza Aghasadeghi, Sayyed Abbas Tabatabai
Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation. Iranian journal of pharmaceutical research : IJPR 21 (1) (2021)
Maryam Nazari, Elham Rezaee, Roshanak Hariri, Tahmineh Akbarzadeh, Sayyed Abbas Tabatabai
Novel 1,2,4-oxadiazole derivatives as selective butyrylcholinesterase inhibitors: Design, synthesis and biological evaluation. EXCLI journal 20 (2021)